Dyne Therapeutics's chart data is dated 2026-10-08. Recorded technical signals: RSI rebound. There are 5 published signal records.
Dyne Therapeutics last closed at $16.37 (+2.50%) on 2026-10-08. Signals today: RSI rebound. Listed on Nasdaq. Trailing 12 months PER is -5.2×. Its overall grade ranks 592 of 738 stocks in Healthcare.
About this company
Dyne Therapeutics last closed at $16.37 (+2.50%) on 2026-10-08. Signals today: RSI rebound. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall D · 592/738
Valuation grade B+
Related stocks
- Vertex PharmaceuticalsCompetitor
근위축성·희귀질환 치료제 분야에서 경쟁 가능한 대형 바이오텍
- Sarepta TherapeuticsCompetitor
희귀 근육질환 치료제 개발로 Dyne과 같은 적응증·테마에서 경쟁
- PfizerCompetitor
근육질환·희귀질환 파이프라인에서 대형 제약사로서 경쟁 가능
ETFs holding this stock
T. Rowe Price Health Care ETF
Details →About Dyne Therapeutics
- What technical signals does Dyne Therapeutics (DYN) have?
- Dyne Therapeutics current technical signals: RSI rebound.
- Is Dyne Therapeutics a cup-and-handle pattern?
- No. Dyne Therapeutics has no valid Cup signal right now.
- What published figures are available for Dyne Therapeutics?
- Market cap: $2.65B. Trailing 12 months PER: -5.2×. Latest quarter PBR: 3.86×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Dyne Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.